Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM | The future role of CAR-T in pediatric ALL

Nirali Shah • 15 Oct 2021
COSTEM
Acute Lymphoblastic Leukemia Leukemia CAR-T

Nirali Shah, MD, National Cancer Institute, National Institutes of Health, Bethesda, MD, shares her view on the future role of chimeric antigen receptor T-cells (CAR-T) in the treatment of pediatric acute lymphoblastic leukemia (ALL).This interview took place at the 6th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), which took place virtually.

More from Nirali Shah

Next steps for improving dual CARs
1:31
Next steps for improving dual CARs
Nirali Shah • 15 Oct 2021
Managing infectious complications of CAR-T therapy
1:11
Managing infectious complications of CAR-T therapy
Nirali Shah • 15 Oct 2021
Prior blinatumomab use impacts CD19-CAR T-cell therapy response rates in R/R ALL
3:42
Prior blinatumomab use impacts CD19-CAR T-cell therapy response rates in R/R ALL
Nirali Shah • 25 Nov 2020
Anti-CD22 CAR T-cell therapy for ALL: trial update, utility for salvage and CD19 status
1:21
Anti-CD22 CAR T-cell therapy for ALL: trial update, utility for salvage and CD19 status
Nirali Shah • 9 Dec 2017

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals